Document is current

Article History

Received: 7 September 2022

Accepted: 4 January 2023

First Online: 19 January 2023

Declarations

:

: The survey was approved by the Western Institutional Review Board (protocol number A3921382). The survey was conducted in accordance with the Western Institutional guidelines. Adelphi DSPs require informed consent from physicians and patients before their participation. Neither patients nor physicians could be identified directly during data collection, and all data were aggregated and de-identified before receipt. Physicians did not see patient responses, thereby ensuring that patient responses did not affect any future physician–patient interactions.

: Not applicable.

: AA has received consulting/advisory board fees from AbbVie, Allergan, Amgen, Arena, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz, Takeda; speaker’s fees from AbbVie, Amgen, Arena, Biogen, Bristol-Myers Squibb, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Novartis, Pfizer, Roche, Samsung Bioepis, Sandoz, Takeda, Tigenix; research support from MSD, Takeda, Pfizer, Biogen. AH has received consultancy fees from Pfizer, payment for lectures from Pfizer, and has participated as an advisory board member for Pfizer. AD has received has received research support or acted as a principal investigator for Abbvie, Celgene/BMS, Dr Falk Pharma, Gilead/Galapagos, Janssen, Pfizer and Takeda; has acted as a consultant for AbbVie, Amgen, Boehringer Ingelheim, Celgene/BMS, Celltrion, Dr Falk Pharma, Ferring, Fresenius Kabi, Janssen, MSD, Pharmacosmos, Pfizer, Roche, Takeda, Tillotts, and Vifor; and has participated in speaker bureaus for AbbVie, Eli Lilly, Falk Foundation, Ferring, Janssen, MSD, Pharmacosmos, Pfizer, Roche, Takeda, Tillotts, and Vifor. JCC, NM and PH are employees and stockholders of Pfizer Inc. BH, FH, and GM are employees of Adelphi Real World, Bollington, UK, which received funding from Pfizer in connection with the development of this manuscript.